Baclofen is a centrally acting gamma-ammino butyric acid agonist that is used like muscular relaxant in disorders with spasticity and intractable hiccups. Although encouraging and safe results were provided 5 mg/day in hemodialysis patients, his pharmacokinetic and pharmacodinamic properties are not well known in end stage renal disease. We present here the case of a hemodialysis patient with intractable hiccups who developed baclofen-associated encephalopathy with this recommended dose.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
hemodialysis patient
8
intractable hiccups
8
[baclofen-associated encephalopathy
4
encephalopathy hemodialysis
4
patient hiccups]
4
hiccups] baclofen
4
baclofen centrally
4
centrally acting
4
acting gamma-ammino
4
gamma-ammino butyric
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!